ADDvise Group AB’s (publ) subsidiary LabRum AB has received an allocation decision from Stockholms Läns Landsting regarding a delivery of CO2 incubators. The incubators will be delivered to Nya Karolinska Solna and will be used for cell and bacteria cultivation. The order is worth approximately 9 MSEK and will be delivered in the second and third quarter of 2017.
- We are proud to be a part of laying the groundwork of the future of research, says Rikard Akhtarzand CEO of ADDvise Group in a comment to the allocation decision.
The agreement has a standstill period until April 10. Not until then LabRum AB has the right to sign the agreement with SLL.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Important information:
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on April 03, 2017 at 09:25 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.